Vectus Biosystems Ltd has released a press release.
Key Accugen Patent Granted in USA
Filed with ASX ·
6ix hasn’t read this filing yet.
Vectus Biosystems Limited on 6ix
Later from Vectus Biosystems
- Scientific Paper on Accugen Technology
- Admission to Official List
- Appendix 4C - Quarterly Report and Update
- Successful Pre-Clinical Trial and Granting of Key Patent
- Appendix 4C - Quarterly
Follow Vectus Biosystems into a list and get an email when it puts out news.
Follow Vectus Biosystems